![#ESMO22 Highlights on the efficacy and safety of fruquintinib in refractory mCRC: The FRESCO-2 study - YouTube #ESMO22 Highlights on the efficacy and safety of fruquintinib in refractory mCRC: The FRESCO-2 study - YouTube](https://i.ytimg.com/vi/qqTeVCr4F_o/mqdefault.jpg)
#ESMO22 Highlights on the efficacy and safety of fruquintinib in refractory mCRC: The FRESCO-2 study - YouTube
![Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study - The Lancet Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study - The Lancet](https://www.thelancet.com/cms/attachment/4f175a76-9098-466d-8845-f8746b855844/gr1_lrg.jpg)
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study - The Lancet
FRESCO-2: A global phase 3 multiregional clinical trial evaluating the efficacy and safety of fruquintinib in patients with refr
![A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967 A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967](https://www.laney.co.uk/images/products/a-fresco-2/large/A-FRESCO-2_Back.png)
A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967
![A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967 A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967](https://www.laney.co.uk/images/products/a-fresco-2/large/A-FRESCO-2_Right.png)
A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967
![FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer | Future Oncology FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2021-0202/asset/images/medium/figure1.gif)
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer | Future Oncology
![A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967 A SERIES A-FRESCO-2 Acoustic instrument combo - 60W - Rechargable Li-Ion battery power - Laney Amplification - Since 1967](https://www.laney.co.uk/images/products/a-fresco-2/large/A-FRESCO-2_Left.png)